1. Zhou, Hong-Zhong, Li, Fan, Cheng, Sheng-Tao, Huang, Ai-Long, Chen, Juan. 2021. DDX17-regulated alternative splicing that produced an oncogenic isoform of PXN-AS1 to promote HCC metastasis. In Hepatology (Baltimore, Md.), 75, 847-865. doi:10.1002/hep.32195. https://pubmed.ncbi.nlm.nih.gov/34626132/
2. Wu, Qiaoling, Cui, Zhaolei, Jiang, Shan, You, Yiqing, Sun, Yang. 2023. Autophagy-related gene PXN as a prognostic marker: Promotion of ovarian cancer progression by suppressing the p110β/Vps34/Beclin1 pathway. In Cell biochemistry and function, 41, 599-608. doi:10.1002/cbf.3815. https://pubmed.ncbi.nlm.nih.gov/37232085/
3. Chen, Hongjin, Hou, Guoqiang, Yang, Jian, Ge, Jianwei, Zhang, Xiaohua. 2020. SOX9-activated PXN-AS1 promotes the tumorigenesis of glioblastoma by EZH2-mediated methylation of DKK1. In Journal of cellular and molecular medicine, 24, 6070-6082. doi:10.1111/jcmm.15189. https://pubmed.ncbi.nlm.nih.gov/32329150/
4. Chen, Yun, Zhao, Han, Xiao, Yan, Guo, Yue, Feng, Yunzhi. 2021. Pan-cancer analysis reveals an immunological role and prognostic potential of PXN in human cancer. In Aging, 13, 16248-16266. doi:10.18632/aging.203154. https://pubmed.ncbi.nlm.nih.gov/34135128/